Clinical Trial Update: Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of cilostazol (Pletaal) for vasospastic angina has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasospastic Angina

Drugs mentioned

• Pletaal (cilostazol)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Variant Angina | Phase 2 | Status: COMPLETED